Apoptotic and anti-apoptotic mechanisms following spinal cord injury

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 5, 2001, Pages 422-429

  Keane, Robert W ^a,b   Kraydieh, Susan ^c   Lotocki, George ^a   Bethea, John R ^b   Krajewski, Stanislaw ^b   Reed, John C ^c   Dietrich, W Dalton ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c BURNHAM INSTITUTE   (United States)

Author keywords

Apoptosis; Apoptosis inhibitors; Caspases; Spinal cord injury

Indexed keywords

APOPTOSIS INHIBITOR; BETA ACTIN; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CYSTEINE PROTEINASE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; FEMALE; GRAY MATTER; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; WHITE MATTER;

EID: 0034996673     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.5.422     Document Type: Article

References (31)

1. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997;1:73-76
2. Shuman SL, Bresnahan JC, Beattie MS. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J Neurosci Res 1997;50:798-808
3. Emery E, Aldana P, Bunge MB, et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg 1998;89:911-20
4. Springer JE, Azbill RD, Knapp PE. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nature Med 1999; 5:943-46
5. Los M, Wesselborg S, Schultze-Osthoff K. The role of caspases in development, immunity, and apoptotic signal transduction: Lessons from knockout mice. Immunity 1999;10:629-39
6. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 2000;403:98-103
7. Boldin MP, Goncharov TM, Goltxev YV, Wallach D. Involvement of MACH, a novel MORTI/FADD-interacting protease, in Fas/ APO-1 and TNF receptor-induced cell death. Cell 1996;85:803-15
8. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex. Cell 1996; 85:817-27
9. Wallach D, Boldin M, Varfolomeev E, Beyaert R, Vandenabeele P, Fiers W. Cell death induction by receptors of the TNF family: Towards a molecular understanding. FEBS Lett 1997;410:96-106
10. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apototic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996;86:147-57
11. Li P, Nijhawan D, Budihardjo I, Srinivasula S, Ahmad M, Alnemeri E, Wang X. Cytochrome c and dATP dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-89
12. Reed JC. Cytochrome C: Can't live with it: Can't live without it. Cell 1997;91:559-62
13. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:405-13
14. Krajewski S, Krajewska M, Ellerby LM, et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci USA 1999;96:5752-57
15. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev 1999;13:239-52
16. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997;16:6914-25
17. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998;17:2215-23
18. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 1999; 18:5242-51
19. Xu DG, Crocker SJ, Doucet JP, et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med 1997;3:997-1004
20. Xu D, Bureau Y, McIntyre DC, et al. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J. Neurosci 1999;19:5026-33
21. Roy N, Mahadevan MS, McLean M, et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995;80:167-78
22. Gruner JA. A monitored contusion model of spinal cord injury in the rat. J Neurotrauma 1992;9:123-26
23. Bethea JR, Nagashima H, Acosta MC, et al. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 1999;16:851-63
24. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000;157:1415-30
25. Hu BR, Chun LL, Ouyang Y, Blomgren K, Siesjo BK. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 2000;20:1294-1300
26. Johnson DE, Gastman BR, Wieckowski E, et al. Inhibitor of apoptosis protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis. Cancer Res 2000;60:1818-23
27. Ambrosini G, Adida C, Altieri D. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21
28. Duckett CS, Nava VE, Gedrich RW, et al. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J 1996;15:2685-89
29. Liston P, Roy N, Tamai K, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996;379:349-53
30. Li F, Ambrosini G, Chu EY, et al. Cell cycle control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396:580-84
31. Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998;58:5315-20